According to Griffen Thorne, a California-based attorney who specializes in cannabis law, that lack of standardization is what makes most regulatory agencies nervous about CBD. “The packaging and labeling requirements aren’t there yet in states that don’t have a cannabis regime,” he told me when I spoke with him about CBD’s sudden popularity in food. “If you go buy a CBD beverage and it’s not specially packaged—it just looks like another coffee or whatever—someone might take a sip who doesn’t intend to.” Purveyors also often make medical claims about CBD’s effects for which there is little scientific proof, including its potential as an anti-inflammatory and a treatment for aches and pains. Thorne said that those promises could also be a source of legal trouble for businesses in the future.
Griffen Thorne in The Atlantic
